<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Assoc Med Bras (1992)</journal-id><journal-id journal-id-type="iso-abbrev">Rev Assoc Med Bras (1992)</journal-id><journal-id journal-id-type="publisher-id">ramb</journal-id><journal-title-group><journal-title>Revista da Associa&#x000e7;&#x000e3;o M&#x000e9;dica Brasileira</journal-title></journal-title-group><issn pub-type="ppub">0104-4230</issn><issn pub-type="epub">1806-9282</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o M&#x000e9;dica Brasileira</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39630731</article-id><article-id pub-id-type="pmc">PMC11639558</article-id>
<article-id pub-id-type="doi">10.1590/1806-9282.20241008</article-id><article-id pub-id-type="other">00603</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Liver/spleen magnetic resonance elastography and T1/T2 mapping in chronic liver disease: a prospective study</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5382-6696</contrib-id><name><surname>&#x000d6;zyurt</surname><given-names>G&#x000f6;khan Mert</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c1" ref-type="corresp">*</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8404-7484</contrib-id><name><surname>Esen</surname><given-names>Kaan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2935-5580</contrib-id><name><surname>&#x000dc;&#x000e7;bilek</surname><given-names>Enver</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2989-1383</contrib-id><name><surname>Apayd&#x00131;n</surname><given-names>Feramuz Demir</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role><role content-type="https://credit.niso.org/contributor-roles/methodology/">Methodology</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Mersin University, School of Medicine, Department of Radiology &#x02013; Mersin, Turkey.</aff><aff id="aff2">
<label>2</label>Mersin University, School of Medicine, Department of Gastroenterology &#x02013; Mersin, Turkey.</aff><author-notes><corresp id="c1">
<label>*</label>Corresponding author: <email>gokhanmertozyurt@gmail.com</email>
</corresp><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> the authors declare there is no conflicts of interest.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>12</month><year>2024</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2024</year></pub-date><volume>70</volume><issue>12</issue><elocation-id>e20241008</elocation-id><history><date date-type="received"><day>14</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2024</year></date></history><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an article published in open access under a Creative Commons license.</license-p></license></permissions><abstract><title>SUMMARY</title><sec><title>OBJECTIVE:</title><p>This study aims to compare liver and spleen stiffness measurements using magnetic resonance elastography with T1 and T2 relaxation times in patients with chronic liver disease.</p></sec><sec><title>METHODS:</title><p>A total of 75 chronic liver disease patients and 25 healthy volunteers underwent MR. Patients with significant liver fat and iron accumulation were excluded. Student&#x02019;s t-test was employed to compare magnetic resonance elastography and T1/T2 values. Pearson&#x02019;s correlation test was used to assess the relationship between magnetic resonance elastography and T1/T2 values.</p></sec><sec><title>RESULTS:</title><p>Liver magnetic resonance elastography showed a significant moderate positive correlation with liver T1 mapping (r=0.51, p&#x0003c;0.001) and liver T2 mapping (r=0.30, p=0.009) in patients. Spleen magnetic resonance elastography exhibited a significant moderate positive correlation with spleen T2 mapping (r=0.37, p=0.001). However, there was no significant correlation between spleen magnetic resonance elastography and spleen T1 mapping in patients. Spleen magnetic resonance elastography was moderately positively correlated with liver magnetic resonance elastography (r=0.30, p=0.01), and spleen volume showed positive correlations with spleen magnetic resonance elastography, spleen T1 mapping, and spleen T2 mapping. Cut-off values for liver magnetic resonance elastography, liver T1 mapping, and liver T2 mapping in patient and control groups were 2.6 kPa (AUC=0.97), 619 ms (AUC=0.90), and 52.5 ms (AUC=0.62), respectively.</p></sec><sec><title>CONCLUSION:</title><p>Relaxation methods offer noninvasive imaging without additional equipment. Liver T1 mapping may serve as an alternative to magnetic resonance elastography for chronic liver patient follow-up, while spleen T1 mapping is not reliable.</p></sec></abstract><kwd-group><title>KEYWORDS:</title><kwd>Magnetic resonance</kwd><kwd>Liver cirrhosis</kwd><kwd>Magnetic resonance elastography</kwd></kwd-group><counts><table-count count="03"/><ref-count count="18"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Understanding hepatic fibrosis in chronic liver disease is crucial in terms of disease prognosis and the follow-up of the patients<sup>
<xref rid="B1" ref-type="bibr">1</xref>
</sup>. While liver biopsy was previously considered the gold standard method for detecting liver fibrosis, recently, magnetic resonance elastography (MRE) has gained importance as a noninvasive method<sup>
<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>
</sup>. MRE offers advantages such as being noninvasive, reproducible, and reliable; however, it has certain limitations, such as the requirement of additional equipment and susceptibility to interference from iron and fat deposition<sup>
<xref rid="B4" ref-type="bibr">4</xref>
</sup>.</p><p>It has been reported that the measurement of T1 relaxation time can differentiate healthy subjects from patients with liver cirrhosis; however, it exhibits lower diagnostic performance compared to MRE<sup>
<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B5" ref-type="bibr">5</xref>
</sup>. T2 relaxation time can also differentiate the severity of fibrosis, and prolonged T2 relaxation time in regions of fibrosis may be associated with the coexistent inflammation and water content of the advanced fibrosis<sup>
<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B6" ref-type="bibr">6</xref>
</sup>. The main advantage of relaxation methods over MRE is that they do not require additional equipment. Liver iron deposition is a prominent technical limitation of both MRE and T1 relaxation measurements. In the liver with iron overload, MRE based on short echo time 2D spin echo echoplanar imaging has been utilized instead of gradient recalled echo MRE<sup>
<xref rid="B7" ref-type="bibr">7</xref>
</sup>. Similarly, the corrected T1 mapping technique that removes the effects of elevated iron from the T1 measurements has been shown to be closely correlated with liver biopsy and reliable for longitudinal monitoring of patients<sup>
<xref rid="B8" ref-type="bibr">8</xref>
</sup>.</p><p>In this study, we aimed to compare MRE and native T1\T2 relaxation times of liver and spleen in chronic liver disease patients and whether T1 and T2 relaxation times can be used as a noninvasive tool in the follow-up of patients.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This single-center prospective study was approved by the local ethics committee, and written informed consent was obtained from all participants. The study received support from the university&#x02019;s scientific research projects unit.</p><p>Between May 2021 and January 2022, a total of 75 volunteer participants diagnosed with chronic liver disease and 25 healthy volunteers were included in the study. Among the healthy volunteers, 23 were males and 2 were females with an average age of 29.5 years (range 21&#x02013;51 years). Among the patients, 42 were males and 33 were females with an average age of 62 years (range 30&#x02013;85 years).</p><p>Volunteers who agreed to participate and had FIB-4&#x0003e;1.5 and/or APRI&#x0003e;0.5 were directed to MRE. Patients with liver stiffness&#x0003e;2.6 kPa were included in the study. Among the patients, 34 cases were associated with hepatitis B, 11 cases with hepatitis C, 16 cases were cryptogenic, 6 cases were associated with alcoholic cirrhosis, 2 cases were due to metabolic causes, 4 cases were related to primary biliary cholangitis, and 2 cases were associated with portal vein thrombosis.</p><p>Patients with pacemakers, implanted insulin or narcotic drug pumps, metallic heart valve prostheses, severe hepatic steatosis, iron accumulation, splenectomy, and a history of aneurysm treated with coils or malignancy were excluded from the study.</p><sec><title>MR protocol</title><p>Magnetic resonance images were acquired using a 1.5-Tesla MR system (Siemens Magnetom Aera; Siemens Medical Systems, Erlangen, Germany) equipped with a 32-channel body coil. An axial 3D multi-gradient-echo sequence with a multistep adaptive fitting algorithm reconstruction (Siemens LiverLab) was used to derive proton density fat fraction and R2* maps for assessing iron accumulation using T2* mapping. The parameters of the MR protocol are listed in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><title>Parameters of MRI protocol.</title></caption><table frame="box" rules="all" cellpadding="5" cellspacing="5"><thead style="background-color:#154573;color:#FFFFFF;"><tr><th align="left" rowspan="2" valign="middle" colspan="1"/><th align="center" colspan="5" valign="middle" rowspan="1">Sequences</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">2D EPI MRE</th><th align="center" valign="top" rowspan="1" colspan="1">MOLLI 5(3)3</th><th align="center" valign="top" rowspan="1" colspan="1">TrueFISP</th><th align="center" valign="top" rowspan="1" colspan="1">T2* (T2 star) map</th><th align="center" valign="top" rowspan="1" colspan="1">Multiecho GRE</th></tr></thead><tbody style="background-color:#E8ECF1;color:#000000;"><tr><td align="left" valign="top" rowspan="1" colspan="1">TE (ms)</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">1.1</td><td align="center" valign="top" rowspan="1" colspan="1">1.04</td><td align="center" valign="top" rowspan="1" colspan="1">1,2,3,5,7,9,11,13,15</td><td align="center" valign="top" rowspan="1" colspan="1">20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TR (ms)</td><td align="center" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">277</td><td align="center" valign="top" rowspan="1" colspan="1">190.39</td><td align="center" valign="top" rowspan="1" colspan="1">200</td><td align="center" valign="top" rowspan="1" colspan="1">15.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FOV (mm<sup>
<xref rid="B2" ref-type="bibr">2</xref>
</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">300x400</td><td align="center" valign="top" rowspan="1" colspan="1">341x400</td><td align="center" valign="top" rowspan="1" colspan="1">321x400</td><td align="center" valign="top" rowspan="1" colspan="1">281x450</td><td align="center" valign="top" rowspan="1" colspan="1">281x450</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Slice thickness (mm)</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Matrix</td><td align="center" valign="top" rowspan="1" colspan="1">48x128</td><td align="center" valign="top" rowspan="1" colspan="1">144x256</td><td align="center" valign="top" rowspan="1" colspan="1">116x192</td><td align="center" valign="top" rowspan="1" colspan="1">128x128</td><td align="center" valign="top" rowspan="1" colspan="1">150x320</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Flip angle</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">70</td><td align="center" valign="top" rowspan="1" colspan="1">160</td><td align="center" valign="top" rowspan="1" colspan="1">160</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Distance factor</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">20%</td><td align="center" valign="top" rowspan="1" colspan="1">20%</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bandwidth (Hz/px)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1,085</td><td align="center" valign="top" rowspan="1" colspan="1">1,184</td><td align="center" valign="top" rowspan="1" colspan="1">1,080</td><td align="center" valign="top" rowspan="1" colspan="1">710</td></tr></tbody></table><table-wrap-foot><fn><p>2D EPI MRE: two-dimensional echoplanar imaging magnetic resonance elastography; MOLLI 5(3)3: 5(3)3 model Modified Look-Locker Inversion; GRE: gradient; TE: time echo; TR: time repetition; FOV: field of view.</p></fn></table-wrap-foot></table-wrap><p>For liver and spleen MRE, a two-dimensional (2D) echoplanar imaging (EPI) technique was employed. To perform the MRE, a passive driver (TelemedWave) was placed on the right upper abdomen for liver imaging and the left upper abdomen for spleen imaging, generating shear waves through continuous acoustic vibrations at a frequency of 60 Hz.</p><p>The 5(3)3 model Modified Look-Locker Inversion (MOLLI) recovery technique was used for liver and spleen T1 mapping, with the following inversion times (TI): 100, 180, 535, 895, 985, 1,220, 1,760, and 2,280 ms. For liver and spleen T2 mapping, the TrueFISP sequence was employed, which required three different preparation times (0, 25, and 55 ms).</p></sec><sec><title>Image analysis</title><p>The image analysis was conducted using the syngo.via software provided by Siemens Healthcare, accessed through a server. The analysis was carried out independently by two readers, each with 4 and 20 years of experience in radiology, respectively. All images were taken at the same level of the liver. Liver MRE, T1 mapping, and T2 mapping measurements were performed by drawing geographic or ellipsoidal regions of interest (ROIs) from the widest possible area in a 95% confidence map, positioned 1 cm away from the portal vein and liver capsule<sup>
<xref rid="B9" ref-type="bibr">9</xref>
</sup>.</p><p>Axial T2-weighted images were loaded into the syngo.via workstation for spleen volume measurement, and a 3D image was generated through multi-planar reconstruction.</p></sec><sec><title>Statistical analysis</title><p>All data were statistically analyzed using the Statistical Package for the Social Sciences program. A significance level of p&#x0003c;0.05 was set for statistical significance. Liver and spleen MRE, T1, and T2 values of healthy volunteers and patients were compared using the Student&#x02019;s t-test, and the correlation between MRE, T1, and T2 values was assessed using the Pearson correlation test.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>When comparing the patient and control groups, statistically significant differences were observed in liver and spleen MRE, T1 mapping, and T2 mapping values (<xref rid="T2" ref-type="table">Table 2</xref>). The patient group exhibited higher values compared to the healthy group. The cut-off values for liver MRE, T1 mapping, and T2 mapping in differentiating between the patient and control groups were 2.6 kPa, 619 ms, and 52 ms, respectively (<xref rid="T3" ref-type="table">Table 3</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><title>Statistics of the patient and control group.</title></caption><table frame="box" rules="all" cellpadding="5" cellspacing="5"><thead style="background-color:#154573;color:#FFFFFF;"><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">n</th><th align="center" valign="top" rowspan="1" colspan="1">Mean</th><th align="center" valign="top" rowspan="1" colspan="1">Standard deviation</th><th align="center" valign="top" rowspan="1" colspan="1">p</th></tr></thead><tbody style="background-color:#E8ECF1;color:#000000;"><tr><td align="left" rowspan="2" valign="middle" colspan="1">Liver MRE</td><td align="center" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td><td align="left" rowspan="2" valign="middle" colspan="1">0.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">5.4</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Spleen MRE</td><td align="center" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">4.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.9</td><td align="left" rowspan="2" valign="middle" colspan="1">0.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient</td><td align="center" valign="top" rowspan="1" colspan="1">74</td><td align="center" valign="top" rowspan="1" colspan="1">9.6</td><td align="center" valign="top" rowspan="1" colspan="1">3.2</td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Liver T1 mapping</td><td align="center" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">578</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="left" rowspan="2" valign="middle" colspan="1">0.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">683</td><td align="center" valign="top" rowspan="1" colspan="1">81</td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Spleen T1 mapping</td><td align="center" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">1,118</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="left" rowspan="2" valign="middle" colspan="1">0.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">1,197</td><td align="center" valign="top" rowspan="1" colspan="1">72</td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Liver T2 mapping</td><td align="center" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="left" rowspan="2" valign="middle" colspan="1">0.004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Spleen T2 mapping</td><td align="center" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">81</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="left" rowspan="2" valign="middle" colspan="1">0.007</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">13</td></tr></tbody></table><table-wrap-foot><fn><p>n: number; MRE: magnetic resonance elastography.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><title>ROC curve analysis of liver magnetic resonance elastography, T1, and T2 values.</title></caption><table frame="box" rules="all" cellpadding="5" cellspacing="5"><thead style="background-color:#154573;color:#FFFFFF;"><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">AUC</th><th align="center" valign="top" rowspan="1" colspan="1">Cut-off</th><th align="center" valign="top" rowspan="1" colspan="1">P</th><th align="center" valign="top" rowspan="1" colspan="1">Sensitivity</th><th align="center" valign="top" rowspan="1" colspan="1">Specificity</th></tr></thead><tbody style="background-color:#E8ECF1;color:#000000;"><tr><td align="left" valign="top" rowspan="1" colspan="1">Liver MRE</td><td align="center" valign="top" rowspan="1" colspan="1">0.970</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;2.6 kPa</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">96 (88&#x02013;99)</td><td align="center" valign="top" rowspan="1" colspan="1">100 (86&#x02013;100)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Liver T1 mapping</td><td align="center" valign="top" rowspan="1" colspan="1">0.902</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;619 ms</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">75 (63&#x02013;84)</td><td align="center" valign="top" rowspan="1" colspan="1">96 (80&#x02013;99)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Liver T2 mapping</td><td align="center" valign="top" rowspan="1" colspan="1">0.621</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;52 ms</td><td align="center" valign="top" rowspan="1" colspan="1">0.0372</td><td align="center" valign="top" rowspan="1" colspan="1">33 (23&#x02013;45)</td><td align="center" valign="top" rowspan="1" colspan="1">100 (86&#x02013;100)</td></tr></tbody></table><table-wrap-foot><fn><p>AUC: area under the curve; MRE: magnetic resonance elastography; ROC: receiver operating characteristic.</p></fn></table-wrap-foot></table-wrap><p>In the comparison of the patient&#x02019;s liver measurements, moderate positive correlations were observed between liver MRE and T1 mapping (r=0.51, p&#x0003c;0.001), liver MRE and T2 mapping (r=0.30, p=0.009), and liver T1 mapping and T2 mapping (r=0.29, p=0.011). A moderate positive correlation was found between spleen T1 mapping and T2 mapping (r=0.40, p&#x0003c;0.001). While a moderately positive correlation was observed between spleen MRE and spleen T2 mapping (r=0.37, p=0.001), no correlation was found between spleen MRE and spleen T1 mapping (p=0.333).</p><p>In the patient group, spleen MRE showed a positive moderate correlation with liver MRE (r=0.30, p=0.01). Although there was no correlation between spleen and liver T1 mapping (p=0.059), a positive correlation was detected between spleen and liver T2 mapping (r=0.49, p&#x0003c;0.001). Spleen volume showed a positive correlation with spleen MRE (r=0.48, p&#x0003c;0.001), spleen T1 mapping (r=0.30, p=0.01), and spleen T2 mapping (r=0.33, p=0.004).</p><p>A simple method widely used for the noninvasive prediction of liver fibrosis, the FIB-4 score, was calculated for all patients. The FIB-4 score was calculated using the formula: age (years) x AST (U/L)/{[PLT (10<sup>9</sup>/L) x ALT (U/L)]}<sup>(1/2)10</sup>. According to the FIB-4 score, 9 patients had mild, 20 had moderate, and 46 had advanced fibrosis.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In the present study, among patients with chronic liver disease, liver T1 and T2 relaxation values obtained from T1 and T2 mapping demonstrated a moderate positive correlation with hepatic stiffness values measured by MRE. The pursuit of an accurate, reliable, noninvasive, and repeatable method for monitoring fibrosis in chronic liver disease is a significant goal for researchers. Relaxation methods and MRE are the primary noninvasive techniques for quantitatively assessing hepatic fibrosis<sup>
<xref rid="B2" ref-type="bibr">2</xref>
</sup>. In recent years, studies comparing the diagnostic performance of these methods taking into account different technical parameters and devices with varying magnetic field strengths have been reported. Ulmenstein et al. reported that T1 mapping exhibited lower diagnostic performance compared to MRE in diagnosing hepatic fibrosis<sup>
<xref rid="B5" ref-type="bibr">5</xref>
</sup>. Conversely, Breit et al. highlighted T1 mapping as a capable predictor for detecting liver fibrosis and cirrhosis<sup>
<xref rid="B11" ref-type="bibr">11</xref>
</sup>. The potential benefits of using T1 mapping with the administration of a contrast agent have also been explored in the literature. In a study conducted by Jin et al., extracellular volume calculated with gadopentetate dimeglumine contrast showed a strong correlation with liver fibrosis<sup>
<xref rid="B12" ref-type="bibr">12</xref>
</sup>. As mentioned earlier, the main objective of this study is to assess a repeatable technique for patient follow-up. In this regard, the possible side effects and cost-effectiveness of contrast agents may pose limitations.</p><p>A systematic review and meta-analysis reported that spleen stiffness may be more specific and accurate than liver stiffness for detecting portal hypertension<sup>
<xref rid="B13" ref-type="bibr">13</xref>
</sup>. The diagnostic performance of spleen stiffness was found to be similar to liver stiffness in predicting advanced liver fibrosis<sup>
<xref rid="B14" ref-type="bibr">14</xref>
</sup>. Talwalkar et al. noted a strong correlation between liver and splenic stiffness (r=0.75)<sup>
<xref rid="B15" ref-type="bibr">15</xref>
</sup>. In our study, spleen MRE exhibited a positive moderate correlation with liver MRE (r=0.30, p=0.01). However, spleen T1 relaxation did not show a correlation, either with spleen MRE (p=0.333) or with liver T1 relaxation (p=0.059). Obmann et al. mentioned a significant difference in spleen T1 relaxation times in patients with liver fibrosis, but the difference between patients with and without liver fibrosis was much smaller in the spleen than in the liver<sup>
<xref rid="B16" ref-type="bibr">16</xref>
</sup>. This might explain the discordance in the current study as the majority of our patients had advanced fibrosis.</p><p>While Cheng et al. found a positive correlation between the splenic volume and liver fibrosis stage, they also noted that the splenic volume was not sensitive in predicting early fibrosis stages<sup>
<xref rid="B14" ref-type="bibr">14</xref>
</sup>. However, in our study, the spleen volume did not exhibit a correlation with liver MRE. We believe this is because we did not classify patients according to the stage of fibrosis. Nevertheless, the spleen volume displayed a positive correlation with spleen MRE (r=0.48, p&#x0003c;0.001), spleen T1 mapping (r=0.30, p=0.01), and spleen T2 mapping (r=0.33, p=0.004).</p><p>Heye et al. reported T1 values for healthy subjects and patients with liver cirrhosis at 1.5T MRI as 678 ms and 852 ms, respectively<sup>
<xref rid="B17" ref-type="bibr">17</xref>
</sup>. Another study conducted with a 1.5T MRI device reported liver T1 relaxation times of 500&#x000b1;79 ms in normal patients, 574&#x000b1;84 ms in Child-Pugh A patients, and 690&#x000b1;147 ms in Child-Pugh B/C patients<sup>
<xref rid="B18" ref-type="bibr">18</xref>
</sup>. In the present study, the mean T1 value in the control and patient groups was 578 ms and 683 ms, respectively. It is important to note that the range of T1 values may vary due to differences in MR equipment and magnetic field inhomogeneity, underscoring the need to establish device-specific reference ranges. Additionally, it is crucial to consider the potential effects of acute liver diseases, hepatic iron overload, and steatosis on T1 mapping. Multiparametric MR imaging techniques that quantify hepatic iron and steatosis alongside mapping are recommended<sup>
<xref rid="B5" ref-type="bibr">5</xref>
</sup>.</p><p>It is essential to acknowledge the limitations of our study, including the preference of MRE as the reference method for liver fibrosis assessment instead of biopsy and the inability to calculate the extracellular volume due to the lack of contrast material. Additionally, while multiple elastogram maps from various levels are commonly obtained in the literature, our study conducted a single-level measurement.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Liver T1 mapping holds promise for the follow-up of chronic liver disease, offering advantages like short examination times and no need for additional equipment. However, factors that may confound T1 relaxation times, such as acute liver diseases, hepatic iron overload, and steatosis must be considered. Furthermore, additional investigations are needed for the routine clinical use of spleen T1 mapping.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This study was supported by the Mersin University Scientific Research Projects Coordination Unit under the project number 2021-1-TP3-4168.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morisaka</surname><given-names>H</given-names></name>
<name><surname>Motosugi</surname><given-names>U</given-names></name>
<name><surname>Ichikawa</surname><given-names>S</given-names></name>
<name><surname>Nakazawa</surname><given-names>T</given-names></name>
<name><surname>Kondo</surname><given-names>T</given-names></name>
<name><surname>Funayama</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging</article-title><source>J Magn Reson Imaging</source><year>2018</year><volume>47</volume><issue>5</issue><fpage>1268</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1002/jmri.25868</pub-id><pub-id pub-id-type="pmid">29030995</pub-id>
</element-citation></ref><ref id="B2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoffman</surname><given-names>DH</given-names></name>
<name><surname>Ayoola</surname><given-names>A</given-names></name>
<name><surname>Nickel</surname><given-names>D</given-names></name>
<name><surname>Han</surname><given-names>F</given-names></name>
<name><surname>Chandarana</surname><given-names>H</given-names></name>
<name><surname>Shanbhogue</surname><given-names>KP</given-names></name>
</person-group><article-title>T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis</article-title><source>Abdom Radiol (NY)</source><year>2020</year><volume>45</volume><issue>3</issue><fpage>692</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1007/s00261-019-02382-9</pub-id><pub-id pub-id-type="pmid">31875241</pub-id>
</element-citation></ref><ref id="B3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mumtaz</surname><given-names>S</given-names></name>
<name><surname>Schomaker</surname><given-names>N</given-names></name>
<name><surname>Roenn</surname><given-names>N</given-names></name>
</person-group><article-title>Pro: noninvasive imaging has replaced biopsy as the gold standard in the evaluation of nonalcoholic fatty liver disease</article-title><source>Clin Liver Dis (Hoboken)</source><year>2019</year><volume>13</volume><issue>4</issue><fpage>111</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1002/cld.750</pub-id><pub-id pub-id-type="pmid">31061704</pub-id>
</element-citation></ref><ref id="B4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guglielmo</surname><given-names>FF</given-names></name>
<name><surname>Venkatesh</surname><given-names>SK</given-names></name>
<name><surname>Mitchell</surname><given-names>DG</given-names></name>
</person-group><article-title>Liver MR elastography technique and image interpretation: pearls and pitfalls</article-title><source>Radiographics</source><year>2019</year><volume>39</volume><issue>7</issue><fpage>1983</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.1148/rg.2019190034</pub-id><pub-id pub-id-type="pmid">31626569</pub-id>
</element-citation></ref><ref id="B5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ulmenstein</surname><given-names>S</given-names></name>
<name><surname>Bogdanovic</surname><given-names>S</given-names></name>
<name><surname>Honcharova-Biletska</surname><given-names>H</given-names></name>
<name><surname>Bl&#x000fc;mel</surname><given-names>S</given-names></name>
<name><surname>Deibel</surname><given-names>AR</given-names></name>
<name><surname>Segna</surname><given-names>D</given-names></name>
<etal/>
</person-group><article-title>Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard</article-title><source>Abdom Radiol (NY)</source><year>2022</year><volume>47</volume><issue>11</issue><fpage>3746</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/s00261-022-03647-6</pub-id><pub-id pub-id-type="pmid">36038643</pub-id>
</element-citation></ref><ref id="B6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guimaraes</surname><given-names>AR</given-names></name>
<name><surname>Siqueira</surname><given-names>L</given-names></name>
<name><surname>Uppal</surname><given-names>R</given-names></name>
<name><surname>Alford</surname><given-names>J</given-names></name>
<name><surname>Fuchs</surname><given-names>BC</given-names></name>
<name><surname>Yamada</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>T2 relaxation time is related to liver fibrosis severity</article-title><source>Quant Imaging Med Surg</source><year>2016</year><volume>6</volume><issue>2</issue><fpage>103</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.21037/qims.2016.03.02</pub-id><pub-id pub-id-type="pmid">27190762</pub-id>
</element-citation></ref><ref id="B7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Serai</surname><given-names>SD</given-names></name>
<name><surname>Trout</surname><given-names>AT</given-names></name>
</person-group><article-title>Can MR elastography be used to measure liver stiffness in patients with iron overload?</article-title><source>Abdom Radiol (NY)</source><year>2019</year><volume>44</volume><issue>1</issue><fpage>104</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00261-018-1723-9</pub-id><pub-id pub-id-type="pmid">30066167</pub-id>
</element-citation></ref><ref id="B8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Banerjee</surname><given-names>R</given-names></name>
<name><surname>Pavlides</surname><given-names>M</given-names></name>
<name><surname>Tunnicliffe</surname><given-names>EM</given-names></name>
<name><surname>Piechnik</surname><given-names>SK</given-names></name>
<name><surname>Sarania</surname><given-names>N</given-names></name>
<name><surname>Philips</surname><given-names>R</given-names></name>
<etal/>
</person-group><article-title>Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease</article-title><source>J Hepatol</source><year>2014</year><volume>60</volume><issue>1</issue><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2013.09.002</pub-id><pub-id pub-id-type="pmid">24036007</pub-id>
</element-citation></ref><ref id="B9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Venkatesh</surname><given-names>SK</given-names></name>
<name><surname>Yin</surname><given-names>M</given-names></name>
<name><surname>Ehman</surname><given-names>RL</given-names></name>
</person-group><article-title>Magnetic resonance elastography of liver: technique, analysis, and clinical applications</article-title><source>J Magn Reson Imaging</source><year>2013</year><volume>37</volume><issue>3</issue><fpage>544</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1002/jmri.23731</pub-id><pub-id pub-id-type="pmid">23423795</pub-id>
</element-citation></ref><ref id="B10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sterling</surname><given-names>RK</given-names></name>
<name><surname>Lissen</surname><given-names>E</given-names></name>
<name><surname>Clumeck</surname><given-names>N</given-names></name>
<name><surname>Sola</surname><given-names>R</given-names></name>
<name><surname>Correa</surname><given-names>MC</given-names></name>
<name><surname>Montaner</surname><given-names>J</given-names></name>
<etal/>
</person-group><article-title>Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection</article-title><source>Hepatology</source><year>2006</year><volume>43</volume><issue>6</issue><fpage>1317</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1002/hep.21178</pub-id><pub-id pub-id-type="pmid">16729309</pub-id>
</element-citation></ref><ref id="B11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Breit</surname><given-names>HC</given-names></name>
<name><surname>Block</surname><given-names>KT</given-names></name>
<name><surname>Winkel</surname><given-names>DJ</given-names></name>
<name><surname>Gehweiler</surname><given-names>JE</given-names></name>
<name><surname>Henkel</surname><given-names>MJ</given-names></name>
<name><surname>Weikert</surname><given-names>T</given-names></name>
<etal/>
</person-group><article-title>Evaluation of liver fibrosis and cirrhosis on the basis of quantitative T1 mapping: are acute inflammation, age and liver volume confounding factors?</article-title><source>Eur J Radiol</source><year>2021</year><volume>141</volume><fpage>109789</fpage><pub-id pub-id-type="doi">10.1016/j.ejrad.2021.109789</pub-id><pub-id pub-id-type="pmid">34051684</pub-id>
</element-citation></ref><ref id="B12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>K</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Zeng</surname><given-names>M</given-names></name>
<name><surname>Rao</surname><given-names>S</given-names></name>
<name><surname>Yan</surname><given-names>L</given-names></name>
<name><surname>Ji</surname><given-names>Y</given-names></name>
<etal/>
</person-group><article-title>A comparative study of MR extracellular volume fraction measurement and two-dimensional shear-wave elastography in assessment of liver fibrosis with chronic hepatitis B</article-title><source>Abdom Radiol (NY)</source><year>2019</year><volume>44</volume><issue>4</issue><fpage>1407</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s00261-018-1860-1</pub-id><pub-id pub-id-type="pmid">30535519</pub-id>
</element-citation></ref><ref id="B13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>R</given-names></name>
<name><surname>Wilson</surname><given-names>MP</given-names></name>
<name><surname>Katlariwala</surname><given-names>P</given-names></name>
<name><surname>Murad</surname><given-names>MH</given-names></name>
<name><surname>McInnes</surname><given-names>MDF</given-names></name>
<name><surname>Low</surname><given-names>G</given-names></name>
</person-group><article-title>Accuracy of liver and spleen stiffness on magnetic resonance elastography for detecting portal hypertension: a systematic review and meta-analysis</article-title><source>Eur J Gastroenterol Hepatol</source><year>2021</year><volume>32</volume><issue>2</issue><fpage>237</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1097/MEG.0000000000001724</pub-id><pub-id pub-id-type="pmid">32282542</pub-id>
</element-citation></ref><ref id="B14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>YW</given-names></name>
<name><surname>Chang</surname><given-names>YC</given-names></name>
<name><surname>Chen</surname><given-names>YL</given-names></name>
<name><surname>Chen</surname><given-names>RC</given-names></name>
<name><surname>Chou</surname><given-names>CT.</given-names></name>
</person-group><article-title>Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><issue>5</issue><fpage>e0217876</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0217876</pub-id><pub-id pub-id-type="pmid">31150508</pub-id>
</element-citation></ref><ref id="B15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Talwalkar</surname><given-names>JA</given-names></name>
<name><surname>Yin</surname><given-names>M</given-names></name>
<name><surname>Venkatesh</surname><given-names>S</given-names></name>
<name><surname>Rossman</surname><given-names>PJ</given-names></name>
<name><surname>Grimm</surname><given-names>RC</given-names></name>
<name><surname>Manduca</surname><given-names>A</given-names></name>
<etal/>
</person-group><article-title>Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension</article-title><source>AJR Am J Roentgenol</source><year>2009</year><volume>193</volume><issue>1</issue><fpage>122</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2214/AJR.07.3504</pub-id><pub-id pub-id-type="pmid">19542403</pub-id>
</element-citation></ref><ref id="B16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Obmann</surname><given-names>VC</given-names></name>
<name><surname>Berzigotti</surname><given-names>A</given-names></name>
<name><surname>Catucci</surname><given-names>D</given-names></name>
<name><surname>Ebner</surname><given-names>L</given-names></name>
<name><surname>Gr&#x000e4;ni</surname><given-names>C</given-names></name>
<name><surname>Heverhagen</surname><given-names>JT</given-names></name>
<etal/>
</person-group><article-title>T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?</article-title><source>Eur Radiol</source><year>2021</year><volume>31</volume><issue>6</issue><fpage>4308</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/s00330-020-07447-8</pub-id><pub-id pub-id-type="pmid">33313965</pub-id>
</element-citation></ref><ref id="B17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heye</surname><given-names>T</given-names></name>
<name><surname>Yang</surname><given-names>SR</given-names></name>
<name><surname>Bock</surname><given-names>M</given-names></name>
<name><surname>Brost</surname><given-names>S</given-names></name>
<name><surname>Weigand</surname><given-names>K</given-names></name>
<name><surname>Longerich</surname><given-names>T</given-names></name>
<etal/>
</person-group><article-title>MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis</article-title><source>Eur Radiol</source><year>2012</year><volume>22</volume><issue>6</issue><fpage>1224</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1007/s00330-012-2378-5</pub-id><pub-id pub-id-type="pmid">22302503</pub-id>
</element-citation></ref><ref id="B18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cassinotto</surname><given-names>C</given-names></name>
<name><surname>Feldis</surname><given-names>M</given-names></name>
<name><surname>Vergniol</surname><given-names>J</given-names></name>
<name><surname>Mouries</surname><given-names>A</given-names></name>
<name><surname>Cochet</surname><given-names>H</given-names></name>
<name><surname>Lapuyade</surname><given-names>B</given-names></name>
<etal/>
</person-group><article-title>MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity</article-title><source>Eur J Radiol</source><year>2015</year><volume>84</volume><issue>8</issue><fpage>1459</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.ejrad.2015.05.019</pub-id><pub-id pub-id-type="pmid">26032126</pub-id>
</element-citation></ref></ref-list></back></article>